Advanced search
Publication Cover
OncoTargets and Therapy Volume 5, 2012 - Issue
Submit an article Journal homepage
60
Views
12
CrossRef citations to date
0
Altmetric
Review

Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study

Lei HuangCenter of Hepatobiliary Surgery, Peking University People’s Hospital, Peking University, Beijing, People’s Republic of China
,
Guang-ming LiCenter of Hepatobiliary Surgery, Peking University People’s Hospital, Peking University, Beijing, People’s Republic of ChinaCorrespondence[email protected]
,
Ji-ye ZhuCenter of Hepatobiliary Surgery, Peking University People’s Hospital, Peking University, Beijing, People’s Republic of China
,
Zhao LiCenter of Hepatobiliary Surgery, Peking University People’s Hospital, Peking University, Beijing, People’s Republic of China
,
Tao LiCenter of Hepatobiliary Surgery, Peking University People’s Hospital, Peking University, Beijing, People’s Republic of China
&
Xi-sheng LengCenter of Hepatobiliary Surgery, Peking University People’s Hospital, Peking University, Beijing, People’s Republic of China
Pages 457-462 | Published online: 20 Dec 2012

References

  • MazzaferroVLlovetJMMiceliRPredicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysisLancet Oncol200910354319058754
  • WilhelmSMCarterCTangLBAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesisCancer Res2004647099710915466206
  • ChangYSAdnaneJTrailPASorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft modelsCancer Chemother Pharmacol20075956157417160391
  • ThomasMMolecular targeted therapy for hepatocellular carcinomaJ Gastroenterol20094413614119148808
  • DallagoLDhondtVAwadaASelected combination therapy with sorafenib a review of clinical data and perspectives in advanced solid tumorsOncologist20081384584818695262
  • KelleyRKVenookAPSorafenib in hepatocellular carcinoma: separating the hype from the hopeJ Clin Oncol2008265845584819029408
  • LlovetJMRicciSMazzaferroVSorafenib in advanced hepatocellular carcinomaN Engl J Med200835937839018650514
  • RimassalLSantoroASorafenib therapy in advanced hepatocellular carcinoma: the SHARP trialExpert Rev Anticancer Ther2009973974519496710
  • LlovetJMBruixJMolecular targeted therapies in hepatocellular carcinomaHepatology2008481312132718821591
  • ChengALKangYKChenZEfficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma a Phase III randomised, double-blind, placebo-controlled trialLancet Oncol200910253419095497
  • SaabSMcTigueMFinnRSSorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients: feasibility and efficacyExp Clin Transplant2010830731321143097
  • SaidiRFShahSARawsonAPTreating hepatocellular carcinoma with sorafenib in liver transplant patients: an initial experienceTransplant Proc2010424582458421168742
  • HuangLZhuJYLiGMPostoperative recurrence of liver malignant tumor after liver transplantationChinese Journal of General Surgery200924984987

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.